119 related articles for article (PubMed ID: 8129566)
1. Treatment of chronic viral hepatitis type B with oral mucosal administration of natural human interferon alpha lozenges.
Caban J; Mossor-Ostrowska J; Zyrkowska-Bieda T; Zejc M; Janas-Skulina U; Cieśla A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):229-35. PubMed ID: 8129566
[TBL] [Abstract][Full Text] [Related]
2. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
3. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
4. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
[TBL] [Abstract][Full Text] [Related]
5. Natural human interferon alpha given orally has different effects on patients with distinct forms of chronic viral hepatitis B.
Georgiades JA; Caban J; Zyrkowska-Bieda T; Zejc M; Jonas-Skulina U; Cieśla A
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):187-94. PubMed ID: 8915525
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
[TBL] [Abstract][Full Text] [Related]
8. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R
Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
[TBL] [Abstract][Full Text] [Related]
10. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
11. Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment.
Sarin SK; Kumar M; Hissar S; Sharma BC
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):374-80. PubMed ID: 16911934
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant.
Husa P; Chalupa P; Stroblová H; Husová L; Slesinger P
Acta Virol; 2001; 45(5-6):293-7. PubMed ID: 12083328
[TBL] [Abstract][Full Text] [Related]
13. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
[TBL] [Abstract][Full Text] [Related]
14. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
[TBL] [Abstract][Full Text] [Related]
15. Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-alpha therapy: correlation with specific IgG subclass responses to HBsAg.
Gregorek H; Dzierzanowska-Fangrat K; Woynarowski M; Jóźwiak P; Witkowska-Vogtt E; Socha J; Syczewska M; Madaliński K
J Hepatol; 2005 Apr; 42(4):486-90. PubMed ID: 15763334
[TBL] [Abstract][Full Text] [Related]
16. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
Akhan SC; Yulugkural Z; Vahaboglu H
Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
[TBL] [Abstract][Full Text] [Related]
19. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
Krastev Z; Jelev D; Antonov K; Alagozian V; Kotzev I
Hepatogastroenterology; 1999; 46(30):3184-8. PubMed ID: 10626183
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary results of the treatment of patients with chronic active hepatitis (CAH) HBsAg+,HBeAg+ with low oral doses of human interferon-alpha].
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz J; Cummins J; Georgiades J
Przegl Epidemiol; 1991; 45(4):325-30. PubMed ID: 1841411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
